Immunoreactivities of amyloid β peptide(1-42) and total τ protein in lumbar cerebrospinal fluid of patients with normal pressure hydrocephalus

被引:26
|
作者
Lins, H
Wichart, I
Bancher, C
Wallesch, CW
Jellinger, KA
Rösler, N
机构
[1] Inst Clin Neurobiol, A-1070 Vienna, Austria
[2] Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany
关键词
cerebrospinal fluid; amyloid beta peptide((1-42)); tau protein; normal pressure hydrocephalus; Alzheimer's disease; dementia;
D O I
10.1007/s00702-003-0075-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Immunoreactivities of amyloid beta peptide((1-42)) (Abeta42-IR) and total tau protein (TTIR) were measured in lumbar cerebrospinal fluid of 48 patients (12 patients in each group) with normal pressure hydrocephalus (NPH), vascular dementia (VD), Alzheimer's disease (AD), Parkinson's disease without dementia (PD) and 24 controls (CON) using sensitive and specific enzyme immunoassays. TTIR in NPH was not significantly changed compared with VD, PD and CON, while NPH-Abeta42-IR was significantly decreased compared with PD and CON. In AD, significant increases of TTIR and significant decreases of Abeta42-IR were found. Using a TTIR by Abeta42 plot, all NPH, PD, and CON samples were within the non-AD plot region. 92% of AD and VD samples were within the AD and non-AD area, respectively. We conclude that combined measurement of Abeta42-IR and TTIR contributes to the differential diagnosis of NPH vs. AD and of AD vs. VD, respectively.
引用
收藏
页码:273 / 280
页数:8
相关论文
共 50 条
  • [1] Phosphorylated tau/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus
    Patel, Sunil
    Lee, Edward B.
    Xie, Sharon X.
    Law, Anica
    Jackson, Eric M.
    Arnold, Steven E.
    Clark, Christopher M.
    Shaw, Leslie M.
    Grady, M. Sean
    Trojanowski, John Q.
    Hamilton, Roy H.
    FLUIDS AND BARRIERS OF THE CNS, 2012, 9
  • [2] Phosphorylated tau/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus
    Sunil Patel
    Edward B Lee
    Sharon X Xie
    Anica Law
    Eric M Jackson
    Steven E Arnold
    Christopher M Clark
    Leslie M Shaw
    M Sean Grady
    John Q Trojanowski
    Roy H Hamilton
    Fluids and Barriers of the CNS, 9 (1)
  • [3] Cerebrospinal Fluid Amyloid-β Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus
    Kawamura, Kaito
    Miyajima, Masakazu
    Nakajima, Madoka
    Kanai, Mitsuyasu
    Motoi, Yumiko
    Nojiri, Shuko
    Akiba, Chihiro
    Ogino, Ikuko
    Xu, Hanbing
    Kamohara, Chihiro
    Yamada, Shinya
    Karagiozov, Kostadin
    Ikeuchi, Takeshi
    Kondo, Akihide
    Arai, Hajime
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 83 (01) : 179 - 190
  • [4] Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease
    Santangelo, Roberto
    Cecchetti, Giordano
    Bernasconi, Maria Paola
    Cardamone, Rosalinda
    Barbieri, Alessandra
    Pinto, Patrizia
    Passerini, Gabriella
    Scomazzoni, Francesco
    Comi, Giancarlo
    Magnani, Giuseppe
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 (01) : 183 - 199
  • [5] Amyloid beta 1-42 in cerebrospinal fluid is associated with cognitive plasticity
    Uttner, Ingo
    Schurig, Niklas
    von Arnim, Christine A. F.
    Lange-Asschenfeldt, Christian
    Brettschneider, Johannes
    Riepe, Matthias W.
    Tumani, Hayrettin
    PSYCHIATRY RESEARCH, 2011, 190 (01) : 132 - 136
  • [6] Traumatic brain injury increases β-amyloid peptide 1-42 in cerebrospinal fluid
    Raby, CA
    Morganti-Kossmann, MC
    Kossmann, T
    Stahel, PF
    Watson, MD
    Evans, LM
    Mehta, PD
    Spiegel, K
    Kuo, YM
    Roher, AE
    Emmerling, MR
    JOURNAL OF NEUROCHEMISTRY, 1998, 71 (06) : 2505 - 2509
  • [7] Use of cerebrospinal fluid amyloid-β and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus Clinical article
    Tarnaris, Andrew
    Toma, Ahmed K.
    Chapman, Miles D.
    Keir, Geoff
    Kitchen, Neil D.
    Watkins, Laurence D.
    JOURNAL OF NEUROSURGERY, 2011, 115 (01) : 145 - 150
  • [8] Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia
    Skillback, Tobias
    Farahmand, Bahman Y.
    Rosen, Christoffer
    Mattsson, Niklas
    Nagga, Katarina
    Kilander, Lena
    Religa, Dorota
    Wimo, Anders
    Winblad, Bengt
    Schott, Jonathan M.
    Blennow, Kaj
    Eriksdotter, Maria
    Zetterberg, Henrik
    BRAIN, 2015, 138 : 2716 - 2731
  • [9] Cerebrospinal fluid tau, phospho-tau181 and β-amyloid1-42 in idiopathic normal pressure hydrocephalus:: a discrimination from Alzheimer's disease
    Kapaki, E. N.
    Paraskevas, G. P.
    Tzerakis, N. G.
    Sfagos, C.
    Seretis, A.
    Kararizou, E.
    Vassilopoulos, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (02) : 168 - 173
  • [10] Low cerebrospinal fluid Amyloid-βeta 1-42 in patients with tuberculous meningitis
    Stroffolini, Giacomo
    Guastamacchia, Giulia
    Audagnotto, Sabrina
    Atzori, Cristiana
    Trunfio, Mattia
    Nigra, Marco
    Di Stefano, Alessandro
    Di Perri, Giovanni
    Calcagno, Andrea
    BMC NEUROLOGY, 2021, 21 (01)